文献速递糖尿病肥胖与代谢综合征

代谢健康与心血管代谢风险聚类:对预测、预防和治疗的启示

Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment.
PubMed 文献 · Lancet Diabetes Endocrinol · 2023-05-05

本综述探讨代谢健康概念与聚类分析识别的心血管代谢风险亚表型在预测、预防和治疗中的价值。作者结论认为,在一般人群中,代谢健康概念和聚类方法均不优于已建立的风险预测模型,但可能有助于改善特定亚组(如不同BMI类别或糖尿病患者)的风险预测;代谢健康概念最便于临床医生应用和与患者沟通;聚类方法可为分配个体至特定病理生理风险组提供证据,但其对预防和治疗是否有帮助仍需确定。

要点

  • 在一般人群中,代谢健康概念和聚类方法均不优于已建立的心血管代谢风险预测模型。
  • 两种亚表型方法可能有助于改善不同BMI类别或糖尿病患者等亚组的心血管代谢风险预测。
  • 代谢健康概念最便于临床医生应用和与患者沟通心血管代谢风险。

核心结论

  • 在一般人群中,代谢健康概念和聚类方法均不优于已建立的风险预测模型,但可能有助于改善特定亚组的心血管代谢风险预测。
  • 代谢健康概念最便于临床医生应用和与患者沟通心血管代谢风险。
  • 聚类方法可为分配个体至特定病理生理风险组提供证据,但是否有助于预防和治疗仍需确定。

研究设计与样本

  • 本综述基于文献分析,讨论代谢健康概念及聚类分析方法识别的心血管代谢风险亚表型。

主要发现

  • 在2040年全球20项主要寿命损失风险因素中,参考预测指向三项代谢风险——高血压、高BMI和高空腹血糖——为最主要的可变风险变量。
  • 代谢健康概念聚焦于重要风险因素的聚集,可识别代谢不健康正常体重或代谢健康肥胖等亚表型,其心血管代谢疾病风险差异显著。
  • 自2018年以来,在聚类分析背景下使用人体测量学、代谢特征和遗传学的研究提出了高风险患者(如糖尿病患者)中的新型代谢亚表型。

临床怎么用

  • 作者认为,代谢健康概念最便于临床医生应用和与患者沟通心血管代谢风险;聚类方法可能用于将个体分配至特定病理生理风险组,但其对预防和治疗是否有帮助仍需确定。

局限性

  • 聚类方法能否有助于预防和治疗仍需确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among 20 leading global risk factors for years of life lost in 2040, reference forecasts point to three metabolic risks-high blood pressure, high BMI, and high fasting plasma glucose-as being the top risk variables. Building upon these and other risk factors, the concept of metabolic health is attracting much attention in the scientific community. It focuses on the aggregation of important risk factors, which allows the identification of subphenotypes, such as people with metabolically unhealthy normal weight or metabolically healthy obesity, who strongly differ in their risk of cardiometabolic diseases. Since 2018, studies that used anthropometrics, metabolic characteristics, and genetics in the setting of cluster analyses proposed novel metabolic subphenotypes among patients at high risk (eg, those with diabetes). The crucial point now is whether these subphenotyping strategies are superior to established cardiometabolic risk stratification methods regarding the prediction, prevention, and treatment of cardiometabolic diseases. In this Review, we carefully address this point and conclude, firstly, regarding cardiometabolic risk stratification, in the general population both the concept of metabolic health and the cluster approaches are not superior to established risk prediction models. However, both subphenotyping approaches might be informative to improve the prediction of cardiometabolic risk in subgroups of individuals, such as those in different BMI categories or people with diabetes. Secondly, the applicability of the concepts by treating physicians and communication of the cardiometabolic risk with patients is easiest using the concept of metabolic health. Finally, the approaches to identify cardiometabolic risk clusters in particular have provided some evidence that they could be used to allocate individuals to specific pathophysiological risk groups, but whether this allocation is helpful for prevention and treatment still needs to be determined.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023. PMID: 37156256. doi:10.1016/S2213-8587(23)00086-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。